SCHEMBL695591

SCHEMBL695591

COCCCc1ccc(C=O)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
CDK1 P06493 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 4/20 0.37
CA2 P00918 1/20 0.36
TRIM24 O15164 1/20 0.36
TYR P14679 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2C8 P10632 1/20 0.35
AKR1B10 O60218 2/20 0.35
AKR1B1 P15121 2/20 0.35
IGF1R P08069 1/20 0.35
ALOX15 P16050 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SIGMAR1 Q99720 1/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23667707 0.80 TDP1 (0.50) TDP1MEN1KMT2AALDH1A1CA2
SCHEMBL15716656 0.80 IGF1R (0.53) MEN1KMT2AALDH1A1IGF1RALOX15
SCHEMBL19497462 0.79 ALDH1A1 (0.49) TDP1MEN1KMT2AALDH1A1TRIM24
SCHEMBL15543635 0.78 CDK1 (0.71) CDK1TRIM24TYRTRIM33IGF1R
SCHEMBL662447 0.78 CDK1 (0.40) TDP1CDK1ALDH1A1CA2SIGMAR1
SCHEMBL11809868 0.76 TDP1 (0.53) TDP1CDK1MEN1KMT2AALDH1A1
SCHEMBL1071710 0.76 CDK1 (0.43) CDK1KMT2AALDH1A1SMN1; SMN2CYP2C8
SCHEMBL21338176 0.74 TDP1 (0.55) TDP1CDK1MEN1KMT2AALDH1A1
SCHEMBL4743206 0.74 ALDH1A1 (0.50) TDP1MEN1KMT2AALDH1A1TRIM24
SCHEMBL91281 0.74 L3MBTL1 (0.43) ALDH1A1GLASMN1; SMN2CYP2C8IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115907-A1 NOVEL COMPOUNDS AS INHIBITORS OF RENIN CADILA HEALTHCARE LIMITED (IN) 2012-05-10 US disclosed
EP-2421828-A2 PIPERIDINE DERIVATIVES AS INHIBITORS OF RENIN Cadila Healthcare Limited (IN) 2012-02-29 EP disclosed
WO-2010122580-A2 NOVEL COMPOUNDS AS INHIBITORS OF RENIN CADILA HEALTHCARE LIMITED (IN) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115907-A1 NOVEL COMPOUNDS AS INHIBITORS OF RENIN REN, ACE, AGTR1 TDP1 2986/4885CDK1 297/4885MEN1 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.